APA (7th ed.) Citation

Y, Y., HK, C., KH, K., SE, P., YJ, K., J, L., . . . YK, K. (2026). Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6-35 Months: Results from a Multinational Phase 3 Randomised Controlled Trial. Vaccines, 14(4), . https://doi.org/10.3390/vaccines14040341

Chicago Style (17th ed.) Citation

Y, Yoon, et al. "Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6-35 Months: Results from a Multinational Phase 3 Randomised Controlled Trial." Vaccines 14, no. 4 (2026). https://doi.org/10.3390/vaccines14040341.

MLA (9th ed.) Citation

Y, Yoon, et al. "Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6-35 Months: Results from a Multinational Phase 3 Randomised Controlled Trial." Vaccines, vol. 14, no. 4, 2026, https://doi.org/10.3390/vaccines14040341.